An expiring FDA program designed to incentivize research in pediatric rare disease may see new life. The Pediatric Rare Disease Priority Review Voucher (RPD PRV) provides sponsors of granted new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results